Pruritus Therapeutics Market (Updated Version Available)

The report offers detailed coverage of Pruritus Therapeutics industry and main market trends. The market research includes historical and forecast market data, demand, application details, price trends, and company shares of the leading Pruritus Therapeutics by geography. The report splits the market size, by volume and value, on the basis of application type and geography.
Pruritus is a sensation that causes the desire or reflex to scratch. Pruritus has resisted many attempts to classify it as any one type of sensory experience. Modern science has shown that Pruritus has many similarities to pain, and while both are unpleasant sensory experiences, their behavioral response patterns are different. Pain creates a withdrawal reflex, whereas Pruritus leads to a scratch reflex.
Skin disease is the fourth leading cause of nonfatal disease burden. Skin diseases include eczema, psoriasis, acne vulgaris, pruritus, alopecia areata, decubitus ulcer, urticaria, scabies, fungal skin diseases, impetigo, abscess, and other bacterial skin diseases, cellulitis, viral warts, molluscum contagiosum, and non-melanoma skin cancer. Among these types, fungal skin diseases and pruritus were in the top 10 most prevalent diseases worldwide in 2010. Thus pruritus therapeutics market is growing with rising prevalence of skin diseases. Moreover, patent expiration of dermatitis drugs and the introduction of new products are also responsible for the growth of pruritus therapeutics market.
The classification of Pruritus Therapeutics includes Corticosteroids, Antihistamines, Calcineurin Inhibitors and other. The proportion of Antihistamines in 2016 is about 21.6%, and the proportion of Corticosteroids is about 22.9%.
North America is the largest consumption place, with a revenue market share nearly 43.4% in 2016. Following North America, Europe is the second largest consumption place with the revenue market share of 27.3%.

The report forecast global Pruritus Therapeutics market to grow to reach xxx Million USD in 2020 with a CAGR of xx% during the period 2021-2025.

First, this report covers the present status and the future prospects of the global Pruritus Therapeutics market for 2015-2025.
And in this report, we analyze global market from 5 geographies: Asia-Pacific[China, Southeast Asia, India, Japan, Korea, Western Asia], Europe[Germany, UK, France, Italy, Russia, Spain, Netherlands, Turkey, Switzerland], North America[United States, Canada, Mexico], Middle East & Africa[GCC, North Africa, South Africa], South America[Brazil, Argentina, Columbia, Chile, Peru].

Key Companies
J&J
Abbott
Amgen
LEO Pharma
Novartis
Bayer
Pfizer
UCB Pharma
GlaxoSmithKline
Galderma
Huapont


At the same time, we classify Pruritus Therapeutics according to the type, application by geography. More importantly, the report includes major countries market based on the type and application.

Market Segment as follows:
Market by Order Type
Antihistamines
Corticosteroids
Other
Market by Application
External Use
Oral
Injection

By Region
Asia-Pacific[China, Southeast Asia, India, Japan, Korea, Western Asia]
Europe[Germany, UK, France, Italy, Russia, Spain, Netherlands, Turkey, Switzerland]
North America[United States, Canada, Mexico]
Middle East & Africa[GCC, North Africa, South Africa]
South America[Brazil, Argentina, Columbia, Chile, Peru]

The research provides answers to the following key questions:
• What is the estimated growth rate and market share and size of the Pruritus Therapeutics market for the forecast period 2021 - 2025?
• What are the driving forces in the Pruritus Therapeutics market for the forecast period 2021 - 2025?
• Who are the prominent market players and how have they gained a competitive edge over other competitors?
• What are the market trends influencing the progress of the Pruritus Therapeutics industry worldwide?
• What are the major challenges and threats restricting the progress of the industry?
• What opportunities does the market hold for the prominent market players?